Steward Partners Investment Advisory, LLC Biocryst Pharmaceuticals Inc Transaction History

Steward Partners Investment Advisory, LLC

  • $10.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 02, 2022
SELL
$11.56 - $19.76 $1,734 - $2,964
-150 Closed
0 $0
Q4 2021

Feb 08, 2022
BUY
$11.18 - $15.46 $1,677 - $2,319
150 New
150 $2,000
Q2 2021

Aug 13, 2021
SELL
$9.5 - $17.24 $9,500 - $17,240
-1,000 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$7.37 - $13.61 $7,370 - $13,610
1,000 New
1,000 $10,000

Others Institutions Holding BCRX

# of Institutions
279
Shares Held
172M
Call Options Held
625K
Put Options Held
739K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.41B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email